key: cord-0274833-wxshxba0
authors: Domínguez-Andrés, Jorge; Kuijpers, Yunus; Bakker, Olivier B.; Jaeger, Martin; Xu, Cheng-Jian; van der Meer, Jos W.M.; Jakobsson, Mattias; Bertranpetit, Jaume; Joosten, Leo A.B.; Li, Yang; Netea, Mihai G.
title: Evolution of cytokine production capacity in ancient and modern European populations
date: 2021-01-16
journal: bioRxiv
DOI: 10.1101/2021.01.14.426690
sha: 885808d6ddd90cb9cc292e2de2b34a23813ef9e8
doc_id: 274833
cord_uid: wxshxba0

As our ancestors migrated throughout the different continents, natural selection increased the presence of alleles advantageous in the new environments. Heritable variations that alter the susceptibility to diseases vary with the historical period, the virulence of the infections, and their geographical spread. In this study we built polygenic scores for heritable traits influencing the genetic adaptation in the production of cytokines and immune-mediated disorders, including infectious, inflammatory, and autoimmune diseases, and applied them to the genomes of several ancient European populations. We observed that the advent of the Neolithic was a turning point for immune-mediated traits in Europeans, favoring those alleles linked with the development of tolerance against intracellular pathogens and promoting inflammatory responses against extracellular microbes. These evolutionary patterns are also associated with an increased presence of traits related to inflammatory and auto-immune diseases.

Human history has been shaped by infectious diseases. Human genes, especially host 51 defense genes, have been constantly influenced by the pathogens encountered 52 (Fumagalli and Sironi, 2014; Karlsson et al., 2014; Quintana-Murci and Clark, 2013) . 53

Pathogens drive the selection of genetic variants affecting resistance or tolerance to 54 the infection, and heritable variations that increase survival to diseases with high 55 morbidity and mortality will be naturally selected in people before reproductive age 56 (Karlsson et al., 2014) . These selection signatures vary with historical period, virulence 57 of the pathogen, and the geographical spread. 58

Here we investigated the historical evolutionary patterns leading to genetic adaptation 59 in cytokine production and immune-mediated diseases, including infectious, 60 inflammatory, and autoimmune diseases. Cytokine production capacity is a key 61 component of the host defense mechanisms: it induces inflammation, activates 62 phagocytes to eliminate the pathogens and present antigens, and controls induction of 63 T-helper adaptive immune responses. We have therefore chosen to investigate the 64 evolutionary trajectories of cytokine production capacity in modern human populations 65 during history. To determine the difference in polygenic regulation of diseases and 66 cytokine production capacity, we used data derived from the 500 Functional Genomics 67 (500FG) cohort of the Human Functional Genomics Project (HFGP; 68 http://www.humanfunctionalgenomics.org). The HFGP is an international collaboration 69 aiming to identify the host and environmental factors responsible for the variability of 70 human immune responses in health and disease . Within the HFGP 71 project, the 500FG study generated a large database of immunological, phenotypic and 72 multi-omics data from a cohort of 534 individuals of Western-European ancestry, which 73 have been used to integrate the impact of genetic and environmental factors on 74 cytokine production and immune parameters. We subsequently deciphered the factors 75 that influence inter-individual variation in the immune responses against different 76 7 pathogens Staphylococcus aureus and Candida albicans indicate increased resistance, 131 with high production of IL-22 and TNFα, respectively. The increased response to the 132 important fungal pathogen C. albicans after the Neolithic period is validated also at 133 transcriptional level. Overall, these patterns are reminiscent of the studies showing that 134 human immune responses need to adapt to a new landscape of infectious agents 135 depending on geographical location and types of microbe encountered (Ferwerda et 136 al., 2007) . Such different patterns were most likely encountered also through history. 137

Importantly, our results also show significant patterns in the changes of the production 138 of specific cytokines during history. The resistance against intracellular pathogens 139 increased after Neolithic with higher IFN responses (see Fig.1 ): indeed, it is known 140 that Th1-IFNγ responses are crucial for the host defense against intracellular 141 pathogens such as mycobacteria or Coxiella (Thakur et al., 2019) . In addition, the 142 resistance to the extracellular pathogens C. albicans and S. aureus is also increased 143 after this Neolithic era, with TNF and IFN production increasing steadily after. These 144 two cytokines are very well known to be important for anti-Candida and anti-145

Staphylococcus host defense (Chan et al., 2018; Domínguez-Andrés et al., 2017) . On 146 the other hand, a different pattern emerges in relation with the IL1-IL6-IL17 axis: the 147 production of these cytokines is decreasing after Neolithic (see Figs. 1a and 1b) . In this 148 context, the decrease through time of poly I:C induction of cytokines, as a model of 149 viral stimulation, is intriguing but potentially very important: many important viruses 150 such as influenza and coronaviruses (SARS, MERS, and SARS-CoV-2) exert life-151 threatening effects through induction of cytokine-mediated hyperinflammation (also 152 termed "cytokine storm') (Tay et al., 2020) : evolutionary processes to curtail this 153 exaggerated responses are thus likely to be protective, and tolerance against viruses 154 become a host defense mechanism (Diard and Hardt, 2017) . 155

These evolutionary genetic adaptations to pathogens throughout human history greatly 156 influence the way we respond to multiple diseases in modern times as well. To assess 157 8 these effects, we calculated the PRS associated with the risk of several highly 158 prevalent immune mediated diseases. The first focus was on common infectious 159 diseases such as malaria, HIV-AIDS, tuberculosis and chronic viral hepatitis; we 160 calculated the changes in susceptibility to these diseases in the last 50.000 years of 161 human history, based on summary statistics from genome-wide association studies 162 (GWAS) databases available from the literature (Fig. S3 ). Our results show that 163 humans are becoming more resistant to these diseases, with the notable exception of 164 tuberculosis, whose risk score remained stable along the period studied (Fig. 2) . These 165 results suggest that humans have built up a genetic makeup which made them more 166 resistant to a variety of microbes. The pattern of this adaptation is very interesting as 167 well, with a suggested decrease of susceptibility to malaria especially in the last 10.000 168 years. The reason for this accelerated resistance after Neolithic might be linked to 169 higher disease prevalence due to increased populations density, as otherwise 170

Plasmodium parasites are known to have circulated in Africa since at least the 171 Paleogene 30 million years ago (Poinar, 2005) , and we have likely inherited it from 172 gorillas (Liu et al., 2010) . Intriguingly, we also observe a strong decrease in 173 susceptibility to HIV: this is a contemporary pathogen, therefore this signal could be 174 due to common genetic and immune pathways with other infections that were present 175 in human populations. The increased resistance to HIV in Europeans may be derived 176 from selective pressures induced by other pathogens such as Yersinia pestis (Duncan 177 et al., 2005) . Our data suggest on the other hand that the source of this increased 178 resistance is even older. 179

In contrast, the lack of genetic adaptation in the susceptibility to tuberculosis is 180

intriguing. This surprising finding may be explained by a concept in which M. 181 tuberculosis is at the same time a pathogen and a symbiont, in which latent infection 182 enhances the resistance against other pathogens and this is why our immune system 183 tolerates mycobacterial presence (Pai et al., 2016) . In this regard, individuals with 9 latent TB exhibit enhanced macrophage functions that may protect against other 185 pathogens through the induction of trained immunity (Joosten et al., 2018) . In this 186 context humanity may not be adapting to tuberculosis because increased resistance 187 against mycobacteria is not evolutionarily advantageous. All in all, these results 188 suggest that the risk of suffering infectious diseases has steadily decreased at least for 189 the last 50000 years as a result of the selection of genetic variants which confer 190 resistance to infections. 191

It has been proposed that the increased prevalence of inflammatory and autoimmune 192 diseases is associated with the immune-related alleles that have been positively 193 selected through evolutionary processes to protect against infections, hence the 194 contrasting differences in the prevalence of autoimmune diseases between populations 195 results from diverse selective pressures (Ramos et al., 2015) . In line with this, it has 196 been hypothesized that genetic variants associated with protection against infectious 197 agents are behind the increased prevalence of autoimmune diseases in populations 198 with low pathogen exposure, such as Europeans (Fumagalli et al., 2011; Raj et al., 199 2013) . To study the changing patterns of susceptibility to autoimmune and 200 inflammatory disease during history, we used publicly available summary statistics from 201 GWAS of digestive tract-related autoimmune and inflammatory diseases and arthritis-202 related diseases (Fig. S4 ) and calculated the PRS for each of samples under study. 203

Interestingly, we observed a robust increase of the genetic variants related with the 204 development of inflammatory diseases in the digestive tract after the Neolithic 205 revolution (Fig. 3) . PRS scores associated with celiac disease, Crohn's disease, 206 ulcerative colitis and inflammatory bowel disease, were strongly associated with the 207 age of the samples, regardless of the P value thresholds or the missing genotype rates 208 used for PRS calculation, showing the robustness of these results (Fig. S2) . The fact 209 that especially intestinal inflammatory pathology is increased after a historical event 210 that fundamentally modified human diet is unlikely to be an accident. Our results are in 211 line with earlier research demonstrating that variants in genes important for immune 212 responses and involved in celiac disease pathophysiology (such as IL-12, IL-18RAP, 213 SH2B3) are under strong positive selection (Zhernakova et al., 2010) . The reasons for 214 the selection pressure on these genes are not completely understood, but an 215 advantage for host defense has been suggested (Zhernakova et al., 2010) . 216

In contrast to intestinal inflammation, the PRS of traits linked with juvenile-idiopathic 217 arthritis, rheumatoid arthritis and multiple sclerosis shows a decrease in genetic 218 susceptibility with the age of the sample after the Neolithic revolution. For pre-Neolithic 219 periods, these patterns had little impact with decreasing PRS for digestive tract 220 diseases and increasing PRS for ankylosing spondylitis and juvenile idiopathic arthritis. 221

A strong decrease in susceptibility to juvenile idiopathic arthritis, rheumatoid arthritis 222 and multiple sclerosis is seen after the Neolithic period (see Fig. 3 ). This is likely linked 223 to the decreased production of the IL-1/IL-6/IL-17 axis described in Fig. 2 , which is 224 particularly important in the pathophysiology of these disorders (Akioka, 2019; Mei et 225 al., 2011) . 226

The significant changes in cytokine production and disease susceptibility in European 227 populations after the Neolithic can be due to selective processes on the one hand (as 228 described above), but also with important demographic changes due to migrations of 229 human communities such as the Anatolians (in Neolithic) or the Yamnaya populations 230 from the Pontic steppe (during the Bronze Age) (Racimo et al., 2020) . In this regard, 231 several loci associated with inflammatory disease displayed a group alleles linked with 232

Crohn's disease, celiac disease and ulcerative colitis in Neolithic Aegeans, the 233 community who spread farming across Europe (Hofmanová et al., 2016) , with several 234 of these alleles showing signs of positive selection in modern Europeans (Raj et al., 235 2013) . In addition, the gene expression PRS of several cytokines based on the cis-and 236 trans-eQTLs from the eQTLGen Consortium (https://www.eqtlgen.org/) displayed a 237 very strong association with time for TNFα after the Neolithic revolution (Fig. 4) . haploid genotype data. This was due to the low genotyping coverage. Samples with 274 variant missingness above 96 percent were filtered out using Plink (Purcell et al., 275 2007) . This was done in order to remove outliers with extremely low coverage. Only 276 samples within Europe were used for this study, these samples were selected based 277 on their geographic location, that is latitude (within 35 and 70 degrees north) and 278 longitude (within 10 degrees west and 40 degrees east). Samples without a carbon-279 dated age were also filtered out. We also selected 250 European samples from the March 2020. The stimulated cytokine response summary statistics from the 500FG 302 cohort of the HFGP were used (Li et al., 2016) . Some complex traits had multiple 303 different sets of summary statistics available. In these cases, the data which was more 304 recent and used bigger cohorts that were either of European or mixed (European and 305 Asian) ancestry were selected. The variants of these summary statistics were then 306 filtered by only keeping bi-allelic variants. Most aDNA genotypes available are pseudo-307 haploid as a consequence of their lower sample quality. We excluded ambiguous SNPs 308 (A/T and C/G) in order to prevent errors due to strand flips present in these pseudo-309 haploid samples. 310 311

Polygenic risk scores were then calculated by first intersecting the filtered variants from 313 the summary statistics with the variants present in the DNA samples. Starting at the 314 most significant variant, all variants within a 250kb window around that variant were 315 excluded until no variants remained. We then multiplied the dosage of these variants 316 with the effect size and these values were summed. If a variant is missing in a sample 317 the dosage is substituted with the average genotyped dosage for that variant within the 318 entire dataset. This way the PRS is not skewed in any specific direction. The formula 319 for this is described below with the score S being the weighted sum of a variant's 320 dosage X n multiplied by its associated weight or beta β n calculated using m variants. 321

We constructed piecewise linear models for each trait by separating the samples into 324 two groups. These two groups consisted of all samples preceding the Neolithic era and 325 those of the Neolithic era and later respectively. We correlated PRS with the carbon 326 dated age of our samples. We then multiplied the -log10 of the correlation P values 327 with the sign of the correlation coefficients. 328 329

In order to test the robustness of our results we calculated PRS using multiple different 331 P value thresholds for QTL inclusion. We used P value thresholds from 10 -3 to 10 -8 for 332 the complex traits obtained through GWAS catalog and the UK Biobank. The 333 thresholds used for the stimulated cytokine responses ranged from 10 -3 to 10 -6 . We 334 also calculated PRS using different variant missingness thresholds. This means we 335 removed samples with a variant missingness rate higher than 96, 90, 80, or 70 percent. 336

All of the results from the piecewise linear models were then used to create a heatmap 337 depicting the consistency and robustness of our observed correlations. 338

Additionally, various window-sizes were used for clumping the QTL's and LD based 339 clumping was also performed excluding variants with an LD greater than 0.2 compared 340 to our lead SNP within a window. In order to see whether our observations were due to 341 sample imbalances between the pre-Neolithic period and the later periods samples 342 originating from the Neolithic period and later were randomly down-sampled to the 343 same number of samples as the pre-Neolithic samples. Correlation coefficients 344 between PRS and sample age were then recalculated for the Neolithic and younger 

After Neolithic revolution 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 10 -5 10 -6 10 -7 10 -8 Missing genotype rate ranged from 0.96, 0.9, 0.8, and 0.7. QTL P value for variants 399 included in our PRS models ranged from 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , and 10 -8 . The color ranged from 0.96, 0.9, 0.8, and 0.7. QTL P value for variants included in our PRS 407 models ranged from 10 -3 , 10 -4 , 10 -5 , and 10 -6 . The color key indicates the range of -408 

Interleukin-6 in juvenile idiopathic arthritis

Integration 453 of multi-omics data and deep phenotyping enables prediction of cytokine 454 responses

The UK Biobank resource with 458 deep phenotyping and genomic data

Protective immunity in recurrent 462

Staphylococcus aureus infection reflects localized immune signatures and 463 macrophage-conferred memory

Genomic Signatures of Selective Pressures and Introgression from 467

Archaic Hominins at Human Innate Immunity Genes

Evolution of bacterial virulence

Reappraisal of the historical selective 476 pressures for the CCR5-Δ32 mutation

TLR4 polymorphisms, infectious diseases, and evolutionary pressure 484 during migration of modern humans

The impact of human 488 activities and lifestyles on the interlinked microbiota and health of humans and of 489 ecosystems

Human genome variability, natural selection and 492 infectious diseases

Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main 495

Selective Pressure through Human Evolution

Early farmers from across 504

Europe directly descended from Neolithic Aegeans

Mycobacterial growth 508 inhibition is associated with trained innate immunity

Natural selection and infectious 511 disease in human populations

Genomics Approach to Understand Variation in Cytokine Production in Humans

Origin of the human malaria parasite Plasmodium 522 falciparum in gorillas

The new NHGRI-EBI Catalog of published 526 genome-wide association studies (GWAS Catalog)

Increased serum IL-17 and IL-23 in the patient with ankylosing 530 spondylitis

Understanding human immune function using the resources 539 from the Human Functional Genomics Project

Plasmodium dominicana n. sp. (Plasmodiidae: Haemospororida

PLINK: A tool set for whole-genome 547 association and population-based linkage analyses

Population genetic tools for dissecting innate 550 immunity in humans

The spatiotemporal spread of human migrations during the 553

Common Risk Alleles for Inflammatory Diseases Are Targets of Recent Positive 556

Selection

Genetics of autoimmune diseases: 558 insights from population genetics

Microbiome to Inflammatory Cytokine Production Capacity

The trinity of COVID-19: 566 immunity, inflammation and intervention

Host 573 and Environmental Factors Influencing Individual Human Cytokine Responses